Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group-Reference-Cited by-同舟云学术

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group

Published:2006-01 Issue:1 Volume:17 Page:29-34
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Jatoi A.,Murphy B.R.,Foster N.R.,Nikcevich D.A.,Alberts S.R.,Knost J.A.,Fitch T.R.,Rowland K.M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/1/29/381059/mdj063.pdf

Reference13 articles.

1. XELOX: Active first-line therapy for patients with metastatic colorectal cancer;Cassidy;J Clin Oncol,2004

2. Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer;Scheithauer;J Clin Oncol,2003

3. Phase II study of capecitabine and oxaliplatin in first-line and second-line treatment of advanced or metastatic colorectal cancer;Borner;J Clin Oncol,2002

4. A phase II study of capecitabine plus oxaliplatin: a new first-line option in metastatic colorectal cancer;Makatsoris;Int J Gastrointestinal Cancer,2005

5. A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer;Hong;Ann Oncol,2004

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902);International Journal of Clinical Oncology;2024-01-16

2. Effect of ramucirumab plus paclitaxel in advanced gastric cancer according to the status of programmed cell death-ligand 1 (PD-L1) expression;Journal of Gastrointestinal Oncology;2023-12

3. Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma;Cancer Cell;2023-07

4. Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902);2023-06-01

5. Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis;Pharmaceuticals;2023-03-30